EUVIMEDEUVIMED entdecken
Crossref

Plant-based natural products against multidrug-resistant cancers: mechanisms of apoptosis induction and cell cycle modulation with a focus on breast cancer

Israa Jameel Hakeem, Abdullah Yahya Abdullah Alzahrani, Munirah Muhammad Al-Rooqi, Rabab Sharf Jassas, Manzoor Ahmad Rather, Jan Mohammad Mir, Saleh Abdel-Mgeed Ahmed

Comptes Rendus. Chimie · 06.11.2026 · 29 (G1) · 669-707

DOI: 10.5802/crchim.478 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Comptes Rendus. Chimie, online erschienen am 06.11.2026. Verfasst von Israa Jameel Hakeem und 6 weiteren Autor:innen. Die Arbeit nennt 162 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) is a frequently diagnosed cancer in women worldwide and imposes a significant burden on healthcare systems. Although chemotherapy remains a primary treatment modality, its efficacy is often compromised by multidrug resistance (MDR), leading to poor clinical outcomes and treatment failure. Multidrug resistance in BC arises through multiple mechanisms, including decreased apoptotic activity, overexpression of ATP-binding cassette (ABC) transporters, alterations in the tumor microenvironment, enhanced DNA repair capacity, and epithelial–mesenchymal transition. Conventional chemotherapeutic agents such as doxorubicin and paclitaxel are effective against BC cells; however, their clinical utility is limited by MDR, severe side effects including cardiotoxicity and neuropathy, and reduced efficacy in resistant tumors. To address these challenges, natural products interfere with resistance mechanisms through diverse pathways, inhibiting efflux pumps such as P-glycoprotein, restoring apoptosis, and modulating signal transduction pathways, including PI3K/Akt and NF- κ B. Furthermore, they induce autophagy, inhibit unregulated cell growth, and modify the tumor microenvironment to enhance therapeutic response. Compounds such as curcumin, silybin, apigenin, berberine, matrine, and β -elemene have been shown to improve the effectiveness of chemotherapy, whether used as monotherapies or in combination with conventional drugs, while exhibiting minimal side effects compared to synthetic medicines. In conclusion, secondary metabolites derived from plants possess significant potential to overcome MDR in breast cancer. Their ability to attack resistance-related mechanisms through multiple pathways not only enhances the effectiveness of current therapy but also offers a promising source of safer and more effective anticancer agents.

Zitieren

APA

Hakeem, I. J., Alzahrani, A. Y. A., Al-Rooqi, M. M., Jassas, R. S., Rather, M. A., Mir, J. M., & Ahmed, S. A. (2026). Plant-based natural products against multidrug-resistant cancers: mechanisms of apoptosis induction and cell cycle modulation with a focus on breast cancer. Comptes Rendus. Chimie, 29(G1), 669-707. https://doi.org/10.5802/crchim.478

Vancouver

Hakeem IJ, Alzahrani AYA, Al-Rooqi MM, Jassas RS, Rather MA, Mir JM, et al. Plant-based natural products against multidrug-resistant cancers: mechanisms of apoptosis induction and cell cycle modulation with a focus on breast cancer. Comptes Rendus. Chimie. 2026;29(G1):669-707. doi:10.5802/crchim.478

BibTeX
@article{Hakeem2026,
  author = {Hakeem, Israa Jameel and Alzahrani, Abdullah Yahya Abdullah and Al-Rooqi, Munirah Muhammad and Jassas, Rabab Sharf and Rather, Manzoor Ahmad and Mir, Jan Mohammad and Ahmed, Saleh Abdel-Mgeed},
  title = {Plant-based natural products against multidrug-resistant cancers: mechanisms of apoptosis induction and cell cycle modulation with a focus on breast cancer},
  journal = {Comptes Rendus. Chimie},
  year = {2026},
  volume = {29},
  number = {G1},
  pages = {669--707},
  doi = {10.5802/crchim.478}
}
Kostenlos starten →